SUMMARY The serum concentrations of the phagocytosis-stimulating peptide, tuftsin, were determined by radioimmunoassay in 21 patients with sickle cell disease and in 12 healthy controls. The mean serum tuftsin concentration was significantly lower in patients with haemoglobin SS disease (154 3 + 35 1 ng/ml; 308-6 ± 70-2 nmol/l, P<0 01) and in patients with haemoglobin SC and CC disease (180-9 ± 42-7 ng/ml; 361-8 ± 85-4 nmol/l, P<0 05) than in healthy controls (228-7 ± 46X7 ng/ml; 4574 ± 93 4 nmol/l). Tuftsin deficiency is an indicator of splenic hypofunction and may contribute to the increased susceptibility of patients with sickle cell disease to severe infection. Najjar 2 with haemoglobin CC disease) and 12 healthy age-matched controls were studied; the patients and controls were aged between 3 and 21 years. The patients were neither infected nor in crisis at the time or during the 6-month period preceding blood collection, and none of them had been transfused in the 6 months before the study. In 7 of the patients with haemoglobin SS disease, Decreased serum tuftsin concentrations in sickle cell disease 561
Howell-Jolly bodies were observed on peripheral blood smears. Consent was obtained from patients or parents; the sera were collected in St Petersburg, Florida, stored at -200C, and shipped frozen to Israel for assay. Serum tuftsin was determined by radioimmunoassay as previously described.5
Results
The mean (±SD) serum tuftsin concentration was significantly lower (Figure) in patients with haemoglobin SS disease (154-3 ± 35-1 ng/ml, P<001) and in patients with haemoglobin SC and haemoglobin CC disease (180-9 ± 42-7 ng/ml, P<0-05) than in healthy controls (228 -7 ± 46 -7 ng/ml). The mean (±SD) serum tuftsin concentration in haemoglobin SS disease patients with Howell-Jolly bodies in their peripheral blood smears was 147 + 44 3 ng/ml (294-0 + 88 -6 nmol/l). 
Discussion

